January 08, 2025 12:30 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates

India remains engaged with US for vaccines, Joe Biden assures to support COVAX

Jun 04, 2021, at 03:59 am

New Delhi/IBNS: The Centre on Thursday informed that the government has been making all efforts to augment the availability of vaccines in India, whether through enhanced production in the country or through supply from abroad.

Pfizer offers 5 cr Covid19 vaccine doses to India with conditions as External Affairs Minister S Jaishankar tours US

May 26, 2021, at 05:44 am

New Delhi/IBNS: Pfizer has offered 5 crore Covid-19 vaccine doses to India albeit with pre-conditions as the country ramps up production amid a raging pandemic.

Pfizer, Moderna won't sell vaccines to states, will deal with Centre: Arvind Kejriwal

May 24, 2021, at 07:26 pm

New Delhi/IBNS: Delhi Chief Minister Arvind Kejriwal on Monday said his government's approach to US pharmaceutical giants, Pfizer and Modern, for anti-COVID-19 vaccine shots went unsuccessful as they would only deal with the Centre and not any state.

Indian govt, Pfizer hit deadlock over issue of legal protection on vaccine side effects: Report

May 22, 2021, at 05:03 am

New Delhi/IBNS: US drug major Pfizer's coronavirus vaccine is facing hurdles in entering the Indian market over demand for legal protection from any adverse effects that may follow after the use of its jabs, a Reuters report said, citing sources.